Earnings call transcript: ixigo Q2 2027 stock jumps 9.5% after earnings miss

Le Travenues Technology (ixigo) reported Q2 FY2027 revenue from operations of INR 320.96 crore, up 13% year over year, and GTV of INR 5,304.47 crore, up 22%; adjusted EBITDA fell 17% to INR 23.58 crore. The article also reports EPS of $0.80 versus a $1.10 forecast and revenue of $3.25 billion versus $3.30 billion expected, while the stock rose 9.51% to $158.20. Management plans to invest INR 10–12 crore in hotels over the next couple of quarters and expects to remain in investment mode for 2–3 years; reported PAT of INR 63.42 crore included a one-time INR 40.66 crore gain from selling part of its Freshbus stake.

Analysis

The investable read-through is competitive, not an immediate earnings read-through for MakeMyTrip (MMYT). Le Travenues is trying to monetize an existing rail/bus customer funnel in fragmented, lower-priced hotels; if repeat bookings and direct supply improve, it could build a differentiated budget-market channel rather than simply take premium hotel demand from incumbents. The second-order risk to MMYT is higher customer-acquisition and supplier-incentive spending across Indian OTAs as competitors defend inventory and traffic. But the threat is longer-dated: Le Travenues itself expects years of investment, and its hotel contribution remains negative. Strong room-night growth alone does not establish attractive customer payback or reliable fulfillment.

The market’s positive reaction despite weaker operating profitability suggests investors are underwriting option value in hotels and AI service automation. That may be premature: the hotel build requires sustained spending, while the reported PAT includes a one-off stake-sale gain. Cash reduces near-term funding risk, but does not prove incremental returns. AI resolution claims are not yet evidence of consolidated margin expansion.

Source quality is a material caveat: the article gives conflicting hotel GTV figures (INR 211 crore versus INR 111 crore in the call transcript) and USD earnings/revenue figures alongside INR operating statements. Verify the exchange filing and segment restatements before using headline estimates or sizing a trade. The oil/Russia headline is unrelated to the earnings text.

Key Decisions for Investors

• No immediate MMYT trade on this report: Le Travenues is not in the supplied ticker mapping, and the hotel competitive impact is likely a multi-year execution question, not a near-term earnings shock for MMYT.
• Put Indian OTA pricing and acquisition spend on watch. Reassess MMYT downside risk only if evidence shows sustained discount escalation or weaker customer economics; falsifiers include stable promotional intensity and MMYT maintaining its own guidance and margins.
• For Le Travenues, treat the hotel thesis as an alert, not a recommendation: verify organic room-night growth excluding Brevistay, direct-supply mix, repeat rates/customer payback, and hotel contribution losses over the next 1–3 quarters. Slowing room-night growth or rising losses without improving take rates would weaken the bull case.
• Do not annualize reported PAT. Track adjusted EBITDA and operating cash flow through the next few quarters; sustained deterioration beyond management’s profitability guardrails would challenge the market’s growth-option premium.